Search results for: 'security product'

This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

09 Apr 2024  |  North America  |  Market Research

Global Medtech Outlook, 2024

New Product Development and Approvals Drive Industry Growth Opportunities

Infographics

×

The Global MedTech Outlook, 2024 presents a comprehensive analysis of the global MedTech industry in terms of growth potential and important market dynamics. The analysis covers major MedTech segments such as cardiovascular, orthopedics, patient monitoring, respiratory devices, neurology, diabetes care, and clinical-grade wearables. It highlights k...

The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for m...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

The Wound care and Wound closure market is expected to grow at a rate of 12-15% during the next 5 years. Wound Management products have a huge growth opportunity due to high incidence of chronic and acute wound patients in India along with a growing middle class population, having greater affordability, rising health awareness and purchasing power....

A promising wound care platform ideally involves optimizing patient local and systemic conditions in conjunction with a notion of a good wound healing environment.Newer products are currently being utilized to either replace or augment different substrates in the wound healing cascade. The present research service on Wound care management technolog...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the d...

Rising incidents of patient deaths are raising questions about medical device efficacy, specifically Class II and Class III medical devices. All medical devices commercialized in the US market must adhere to 510(k) compliance. The US Food and Drug Administration (FDA) posts summaries of information about the most serious medical device recalls. ...